Meet our team

Kristin Bloink
Elanco Animal Health
Vice President, Global Research and External Innovation

Justine Conway
Elanco
Vice President | Global Head of Business Development

Kelly Doucette
Elanco
Global Technical Services-Dermatology/Oncology/Specialty Medicine

Lucas Huntimer
Elanco

Jessy Kuo
Elanco
Advisor

Cheryl London
Elanco
External Academic Partner

Mr Steve Nanchen
Elanco Animal Health
Senior Advisor, External Innovation

Suresh Pitram
Elanco Animal Health
Senior Advisor, External Innovation

Steve Sanders
Elanco

Aaron Schacht
Elanco
Executive Vice President - Innovation, Regulatory & Business Development

Sandra Siegel
Elanco

Tari Suprapto
Elanco
Sr Advisor, External Innovation

Bruce Taillon
Elanco Animal Health
Senior Director, External Innovation

About Us

View our session

Name
Canine Oncology Opportunities in Translational Medicine
Date & Time
Tuesday, October 13, 2020, 9:00 AM - 10:00 AM
Cheryl London Bruce Taillon Sandra Siegel
Description

Cancer is now the leading cause of death in pets. If we look at humans, statistically, cancer is one of the top causes of death in humans around the globe and there is a lot of medical literature and ongoing research on the development, treatment, and control of the disease. However, when it comes to cancer in animals, research and knowledge are limited and the disease is as common in pets as it is in humans, specifically in dogs. Nearly 30% of the
cats and 50% of the dogs in the US are diagnosed with a type of cancer after crossing the age of ten. There is great opportunity here to solve a serious unmet medical need. Hosted by Elanco Animal Health, this presentation will provide a case study and example of how to realise the opportunities for canine oncology in animal health today.

Session Type
Presentation
Virtual Session Link

VIEW OUR USEFUL RESOURCES